An observational study investigating the treatment satisfaction of atopic dermatitis patients who have switched to ointment (W/O emulsion) formulation of Very Strong Class topical corticosteroids

Phase 4

• Conditions: atopic dermatitis

• Registration Number: JPRN-UMIN000019873
• Lead Sponsor: Mie University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-11-20
• Study Completion: 2016-11-17
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with any contraindication to TCs 2) Patients who are pregnant or breastfeeding 3) Patients who are regarded as ineligible by the investigator

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Treatment satisfaction measured by Treatment Satisfaction Questionnaire for Medication (TSQM-9)

Secondary Outcome Measures

Name	Time	Method
-Treatment adherence measured by Morisky Medication Adherence Scale (MMAS-8-Item) -Treatment effectiveness measured by Visual Analogue Scale (VAS) for itch and change in severity score measured by Severity Scoring of Atopic -Dermatitis (SCORAD) and Eczema Area and Severity Index (EASI).